MDxHealth (MDXH) Gains from Investment Securities (2021 - 2026)

MDxHealth has disclosed Gains from Investment Securities across 5 years of filings, most recently posting $12000.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $12000.0, down 98.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (up 97.32% YoY), and the FY2025 annual result was -$822000.0, down 387.41% from the prior year.
• Gains from Investment Securities came in at $12000.0 for Q1 2026 at MDxHealth, down from $2.1 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $197.2 million in Q3 2022 to a low of -$197.0 million in Q2 2022.
• The 4-year median for Gains from Investment Securities is $495000.0 (2024), against an average of $767600.0.
• Across the five-year window, Gains from Investment Securities plunged 112.92% in 2022 and jumped 539.89% in 2025, its largest moves.
• MDxHealth's Gains from Investment Securities stood at -$692000.0 in 2022, then jumped by 153.61% to $371000.0 in 2024, then soared by 466.04% to $2.1 million in 2025, then tumbled by 99.43% to $12000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $12000.0 (Q1 2026), $2.1 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.